Ali, S, Stone, MA, Peters, JL, Davies, MJ and Khunti, K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Medicine 23(11), 1165–1173.
Anderson, RJ, Freedland, KE, Clouse, RE and Lustman, PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6), 1069–1078.
Benarroch, EE (2014) Brain glucose transporters: implications for neurologic disease. Neurology 82(15), 1374–1379.
Bough, KJ, Wetherington, J, Hassel, B, Pare, JF, Gawryluk, JW, Greene, JG, Shaw, R, Smith, Y, Geiger, JD and Dingledine, RJ (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Annals of Neurology 60(2), 223–235.
Brunengraber, H and Roe, CR (2006) Anaplerotic molecules: current and future. Journal of Inherited Metabolic Disease 29(2–3), 327–331.
Buttenschon, HN, Krogh, J, Nielsen, MN, Kaerlev, L, Nordentoft, M and Mors, O (2017) Association analyses of depression and genes in the hypothalamus-pituitary-adrenal axis. Acta Neuropsychiatrica 29(1), 59–64.
Cahill, GF Jr (2006) Fuel metabolism in starvation. Annual Review Nutrition 26(1), 1–22.
Carlin, JM, Borden, EC, Sondel, PM and Byrne, GI (1989) Interferon-induced indoleamine 2, 3-dioxygenase activity in human mononuclear phagocytes. Journal of Leukocyte Biology 45(1), 29–34.
Castellano, CA, Nugent, S, Paquet, N, Tremblay, S, Bocti, C, Lacombe, G, Imbeault, H, Turcotte, E, Fulop, T and Cunnane, SC (2015) Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer’s disease dementia. Journal of Alzheimer's Disease 43(4), 1343–1353.
Chisholm, D, Sweeny, K, Sheehan, P, Rasmussen, B, Smit, F, Cuijpers, P and Saxena, S (2016) Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry 3(5), 415–424.
Cowles, MK, Pariante, CM and Nemeroff, CB (2009) Depression in the medically ill. In: Pariante, CM, Nesse, RM, Nutt, DJ and Wolpert, L (eds) Understanding Depression: A Translational Approach. Oxford, UK: Oxford University Press.
Cunnane, SC, Courchesne-Loyer, A, St-Pierre, V, Vandenberghe, C, Pierotti, T, Fortier, M, Croteau, E and Castellano, CA (2016a) Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer’s disease. Annals of the New York Academy of Sciences 1367(1), 12–20.
Cunnane, SC, Courchesne-Loyer, A, Vandenberghe, C, St-Pierre, V, Fortier, M, Hennebelle, M, Croteau, E, Bocti, C, Fulop, T and Castellano, C-A (2016b) Can Ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer’s disease. Frontiers in Molecular Neuroscience 9, 53.
Dowlati, Y, Herrmann, N, Swardfager, WL, Reim, EK and Lanctot, KL (2010) Efficacy and tolerability of antidepressants for treatment of depression in coronary artery disease: a meta-analysis. Canadian Journal of Psychiatry 55(2), 91–99.
Gal, EM and Sherman, AD (1980) L-kynurenine: its synthesis and possible regulatory function in brain. Neurochemical Research 5(3), 223–239.
Gillespie, MT and Horwood, NJ (1998) Interleukin-18: perspectives on the newest interleukin. Cytokine and Growth Factor Reviews 9(2), 109–116.
Gonzalez, JS, Peyrot, M, McCarl, LA, Collins, EM, Serpa, L, Mimiaga, MJ and Safren, SA (2008) Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care 31(12), 2398–2403.
Gonzalez, JS, Shreck, E, Psaros, C and Safren, SA (2015) Distress and type 2 diabetes-treatment adherence: a mediating role for perceived control. Health Psychology 34(5), 505–513.
Grant, RS and Kapoor, V (1998) Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. Journal of Neurochemistry 70(4), 1759–1763.
Guillemin, GJ and Brew, BJ (2002) Implications of the kynurenine pathway and quinolinic acid in Alzheimer’s disease. Redox Report 7(4), 199–206.
Guillemin, GJ, Smythe, G, Takikawa, O and Brew, BJ (2005) Expression of indoleamine 2, 3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49(1), 15–23.
Guillemin, GJ, Wang, L and Brew, BJ (2005) Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. Journal of Neuroinflammation 2, 16.
Han, Q, Cai, T, Tagle, DA and Li, J (2010) Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cellular and Molecular Life Sciences 67(3), 353–368.
Heckbert, SR, Rutter, CM, Oliver, M, Williams, LH, Ciechanowski, P, Lin, EH, Katon, WJ and Von Korff, M (2010) Depression in relation to long-term control of glycemia, blood pressure, and lipids in patients with diabetes. Journal of General Internal Medicine 25(6), 524–529.
Julio-Pieper, M and Dinan, TG (2011) The hypothalamic-pituitary-adrenal axis in depression. Modern Trends in Psychiatry 27, 20–31.
Jurcovicova, J (2014) Glucose transport in brain – effect of inflammation. Endocrine Regulations 48(1), 35–48.
Katon, WJ, Rutter, C, Simon, G, Lin, EH, Ludman, E, Ciechanowski, P, Kinder, L, Young, B and Von Korff, M (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28(11), 2668–2672.
Kessing, LV, Dam, H, Jorgensen, OS and Bolwig, TG (1996) Cognitive impairment in affective disorders – Relation to illness characteristics. Nordic Journal of Psychiatry 50(4), 305–316.
Kloiber, S, Ising, M, Reppermund, S, Horstmann, S, Dose, T, Majer, M, Zihl, J, Pfister, H, Unschuld, PG, Holsboer, F and Lucae, S (2007) Overweight and obesity affect treatment response in major depression. Biological Psychiatry 62(4), 321–326.
Knol, MJ, Twisk, JW, Beekman, AT, Heine, RJ, Snoek, FJ and Pouwer, F (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus: a meta-analysis. Diabetologia 49(5), 837–845.
Köhler-Forsberg, O, Sylvia, L, Deckersbach, T, Ostacher, MJ, McInnis, M, Iosifescu, D, Bowden, C, McElroy, S, Calabrese, J, Thase, M, Shelton, RC, Tohen, M, Kocsis, J, Friedman, E, Ketter, T and Nierenberg, AA (2018) Clinically relevant and simple immune system measure is related to symptom burden in bipolar disorder. Acta Neuropsychiatrica 30(5), 297–305.
Kokoszka, A, Pouwer, F, Jodko, A, Radzio, R, Mucko, P, Bienkowska, J, Kuligowska, E, Smoczynska, O and Sklodowska, Z (2009) Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: a Polish study from the European Depression in Diabetes (EDID) Research Consortium. European Psychiatry 24(7), 425–430.
Koslow, SH, Stokes, PE, Mendels, J, Ramsey, A and Casper, R (1982) Insulin tolerance test: human growth hormone response and insulin resistance in primary unipolar depressed, bipolar depressed and control subjects. Psychological Medicine 12(1), 45–55.
Lapin, IP (1973) Kynurenines as probable participants of depression. Pharmakopsychiatr Neuropsychopharmakol 6(6), 273–279.
Lee, YJ, Han, SB, Nam, SY, Oh, KW and Hong, JT (2010) Inflammation and Alzheimer’s disease. Archives of Pharmacal Research 33(10), 1539–1556.
Leonard, BE (2011) The concept of depression as a dysfunction of the immune system. Modern Trends in Psychiatry 27, 53–71.
Leonard, BE (2018) Chronic inflammation and resulting neuroprogression in major depression. In: Kim, Y-K (ed) Understanding Depression: Volume 1 Biomedical and Neurobiological Background. Singapore: Springer Singapore, pp. 191–196.
Leonard, BE (2018) Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatrica 30(1), 1–16.
Liu, XC, Erhardt, S, Goiny, M, Engberg, G and Mathé, AA (2017) Decreased levels of kynurenic acid in prefrontal cortex in a genetic animal model of depression. Acta Neuropsychiatrica 29(1), 54–58.
Liu, Y, Ho, RC-M and Mak, A (2012) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of Affective Disorders 139(3), 230–239.
Lotrich, FE (2015) Inflammatory cytokine-associated depression. Brain Research 1617, 113–125.
Luppino, FS, de Wit, LM, Bouvy, PF, Stijnen, T, Cuijpers, P, Penninx, BW and Zitman, FG (2010) Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry 67(3), 220–229.
Lustman, PJ, Anderson, RJ, Freedland, KE, de Groot, M, Carney, RM and Clouse, RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23(7), 934–942.
Maeda, N, Takahashi, M, Funahashi, T, Kihara, S, Nishizawa, H, Kishida, K, Nagaretani, H, Matsuda, M, Komuro, R, Ouchi, N, Kuriyama, H, Hotta, K, Nakamura, T, Shimomura, I and Matsuzawa, Y (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50(9), 2094–2099.
Marano, CM, Workman, CI, Lyman, CH, Kramer, E, Hermann, CR, Ma, YL, Dhawan, V, Chaly, T, Eidelberg, D and Smith, GS (2014) The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging. Psychiatry Research: Neuroimaging 222(1–2), 84–90.
Maudsley, H (1879) The Pathology of Mind. Macmillan and Company.
McIntyre, RS, Soczynska, JK, Konarski, JZ, Woldeyohannes, HO, Law, CW, Miranda, A, Fulgosi, D and Kennedy, SH (2007) Should depressive syndromes be reclassified as ‘metabolic syndrome type II’? Annals of Clinical Psychiatry 19(4), 257–264.
Mergenthaler, P, Lindauer, U, Dienel, GA and Meisel, A (2013) Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosciences 36(10), 587–597.
Mezuk, B, Eaton, WW, Albrecht, S and Golden, SH (2008) Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31(12), 2383–2390.
Miller, GE, Chen, E, Sze, J, Marin, T, Arevalo, JM, Doll, R, Ma, R and Cole, SW (2008) A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappa B signaling. Biological Psychiatry 64(4), 266–272.
Mochel, F, Duteil, S, Marelli, C, Jauffret, C, Barles, A, Holm, J, Sweetman, L, Benoist, JF, Rabier, D, Carlier, PG and Durr, A (2010) Dietary anaplerotic therapy improves peripheral tissue energy metabolism in patients with Huntington’s disease. European Journal of Human Genetics 18(9), 1057–1060.
Morford, M (2014) Glucose for the brain: fuel or poison? South African Journal of Anaesthesia and Analgesia 17(1), 70–72.
Moussavi, S, Chatterji, S, Verdes, E, Tandon, A, Patel, V and Ustun, B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet (London, England) 370(9590), 851–858.
Murray, CJL and Lopez, AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet (London, England) 349(9063), 1436–1442.
Myint, AM (2013) Inflammation, neurotoxins and psychiatric disorders. Modern Trends Pharmacopsychiatry 28, 61–74.
Myint, AM and Kim, YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Medical Hypotheses 61(5–6), 519–525.
Nemeroff, CB and Goldschmidt-Clermont, PJ (2012) Heartache and heartbreak-the link between depression and cardiovascular disease. Nature Reviews Cardiology 9(9), 526–539.
Nouwen, A, Winkley, K, Twisk, J, Lloyd, CE, Peyrot, M, Ismail, K, Pouwer, F and European Depression in Diabetes Research Consortium (2010) Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 53(12), 2480–2486.
Ojala, J, Alafuzoff, I, Herukka, SK, van Groen, T, Tanila, H and Pirttila, T (2009) Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients. Neurobiology of Aging 30(2), 198–209.
Oskooilar, N, Wilcox, CS, Tong, ML and Grosz, DE (2009) Body mass index and response to antidepressants in depressed research subjects. Journal of Clinical Psychiatry 70(11), 1609–1610.
Ownby, RL, Crocco, E, Acevedo, A, John, V and Loewenstein, D (2006) Depression and risk for Alzheimer disease – systematic review, meta-analysis, and metaregression analysis. Archives Of General Psychiatry 63(5), 530–538.
Oxenkrug, G (2013a) Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways. Molecular Neurobiology 48(2), 294–301.
Oxenkrug, G (2013b) Serotonin-kynurenine hypothesis of depression: historical overview and recent developments. Current Drug Targets 14(5), 514–521.
Oxenkrug, GF (2010) Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Israel Journal of Psychiatry and Related Sciences 47(1), 56–63.
Paddick, SM, Kisoli, A, Mkenda, S, Mbowe, G, Gray, WK, Dotchin, C, Ogunniyi, A, Kisima, J, Olakehinde, O, Mushi, D and Walker, RW (2017) Adaptation and validation of the Alzheimer’s Disease Assessment Scale – Cognitive (ADAS-Cog) in a low-literacy setting in sub-Saharan Africa. Acta Neuropsychiatrica 29(4), 244–251.
Pailla, K, El-Mir, MY, Cynober, L and Blonde-Cynober, F (2001) Cytokine-mediated inhibition of ketogenesis is unrelated to nitric oxide or protein synthesis. Clinical Nutrition 20(4), 313–317.
Papakostas, GI, Petersen, T, Iosifescu, DV, Burns, AM, Nierenberg, AA, Alpert, JE, Rosenbaum, JF and Fava, M (2005) Obesity among outpatients with major depressive disorder. International Journal of Neuropsychopharmacology 8(1), 59–63.
Perkins, MN and Stone, TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Research 247(1), 184–187.
Kokoszka, A, Pouwer, F, Jodko, A, Radzio, R, Mucko, P, Bienkowska, J, Kuligowska, E, Smoczynska, O and Sklodowska, Z (2005) Serious diabetes-specific emotional problems and depression in a Croatian-Dutch-English Survey from the European Depression in Diabetes [EDID] research consortium. Diabetes Research and Clinical Practice 70(2), 166–173.
Rasgon, N and Jarvik, L (2004) Insulin resistance, affective disorders, and Alzheimer’s disease: review and hypothesis. Journals of Gerontology Series A: Biological Sciences and Medical Science 59(2), 178–183.
Reaven, GM (1988) Role of insulin resistance in human-disease. Diabetes 37(12), 1595–1607.
Roopan, S and Larsen, ER (2017) Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review. Acta Neuropsychiatrica 29(3), 127–139.
Rotella, F and Mannucci, E (2013) Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. Journal of Clinical Psychiatry 74(1), 31–37.
Rotella, F and Mannucci, E (2013) Diabetes mellitus as a risk factor for depression: a meta-analysis of longitudinal studies. Diabetes Research and Clinical Practice 99(2), 98–104.
Roy, M, Beauvieux, MC, Naulin, J, El Hamrani, D, Gallis, JL, Cunnane, SC and Bouzier-Sore, AK (2015) Rapid adaptation of rat brain and liver metabolism to a ketogenic diet: an integrated study using (1)H- and (13)C-NMR spectroscopy. Journal of Cerebral Blood Flow & Metabolism 35(7), 1154–1162.
Sapolsky, RM (1996) Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress (Amsterdam, Netherlands) 1(1), 1–19.
Sas, K, Robotka, H, Toldi, J and Vecsei, L (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. Journal of the Neurological Sciences 257(1–2), 221–239.
Satyanarayana, U and Rao, BS (1980) Dietary tryptophan level and the enzymes of tryptophan NAD pathway. British Journal of Nutrition 43(1), 107–113.
Schwarcz, R and Kohler, C (1983) Differential vulnerability of central neurons of the rat to quinolinic acid. Neuroscience Letters 38(1), 85–90.
Seligman, F and Nemeroff, CB (2015) The interface of depression and cardiovascular disease: therapeutic implications. In: Fink, ME, Barchas, JD, Sheikh, JI (eds) Affective Disorders and Traumatic Brain Injury. Annals of the New York Academy of Sciences, 1345, pp. 25–35.
Sheline, YI, Mittler, BL and Mintun, MA (2002) The hippocampus and depression. European Psychiatry: Journal of Association European Psychiatrists 17(Suppl. 3), 300–305.
Shelton, RC and Miller, AH (2010) Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Progress in Neurobiology 91(4), 275–299.
Sofic, E, Halket, J, Przyborowska, A, Riederer, P, Beckmann, H, Sandler, M and Jellinger, K (1989) Brain quinolinic acid in Alzheimer’s dementia. European Archives of Psychiatry and Clinical Neuroscience 239(3), 177–179.
Solomon, SS, Odunusi, O, Carrigan, D, Majumdar, G, Kakoola, D, Lenchik, NI and Gerling, IC (2010) TNF-alpha inhibits insulin action in liver and adipose tissue: a model of metabolic syndrome. Hormone and Metabolic Research 42(2), 115–121.
Sotelo, JL and Nemeroff, CB (2017) Depression as a systemic disease. Personalized Medicine in Psychiatry 1–2, 11–25.
Steiner, J, Bielau, H, Brisch, R, Danos, P, Ullrich, O, Mawrin, C, Bernstein, HG and Bogerts, B (2008) Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. Journal of Psychiatric Research 42(2), 151–157.
Takahashi, M, Oda, Y, Sato, K and Shirayama, Y (2018) Vascular risk factors and the relationships between cognitive impairment and hypoperfusion in late-onset Alzheimer’s disease. Acta Neuropsychiatrica 30(6), 350–358.
Taylor, MW and Feng, GS (1991) Relationship between interferon-gamma, indoleamine 2, 3-dioxygenase, and tryptophan catabolism. FASEB Journal 5(11), 2516–2522.
Toups, MS and Trivedi, MH (2011) Role of metabolic dysfunction in treatment resistance of major depressive disorder. Neuropsychiatry 1(5), 441–455.
Uher, R, Mors, O, Hauser, J, Rietschel, M, Maier, W, Kozel, D, Henigsberg, N, Souery, D, Placentino, A, Perroud, N, Dernovsek, MZ, Strohmaier, J, Larsen, ER, Zobel, A, Leszczynska-Rodziewicz, A, Kalember, P, Pedrini, L, Linotte, S, Gunasinghe, C, Aitchison, KJ, McGuffin, P and Farmer, A (2009) Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of Affective Disorders 118(1–3), 147–154.
Vancampfort, D, Mitchell, AJ, De Hert, M, Sienaert, P, Probst, M, Buys, R and Stubbs, B (2015) Type 2 diabetes in patients with major depressive disorder: a meta-analysis of prevalence estimates and predictors. Depression and Anxiety 32(10), 763–773.
Vinberg, M, Højman, P, Pedersen, BK, Kessing, LV and Miskowiak, KW (2018) Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders. Acta Neuropsychiatrica 30(6), 342–349.
Weinstein, SP, Paquin, T, Pritsker, A and Haber, RS (1995) Glucocorticoid-induced insulin-resistance – dexamethasone inhibits the activation of glucose-transport in rat skeletal-muscle by both insulin-related and non-insulin-related stimuli. Diabetes 44(4), 441–445.
Werner, H and LeRoith, D (2014) Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects. European Neuropsychopharmacology 24(12), 1947–1953.
Werner, H, Raizada, MK, Mudd, LM, Foyt, HL, Simpson, IA, Roberts, CT and Leroith, D (1989) Regulation of rat-brain hepg2 glucose transporter gene-expression by insulin and insulin-like growth factor-i in primary cultures of neuronal and glial-cells. Endocrinology 125(1), 314–320.
Wilkins, HM, Koppel, S, Carl, SM, Ramanujan, S, Weidling, I, Michaelis, ML, Michaelis, EK and Swerdlow, RH (2016) Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure. Journal of Neurochemistry 137(1), 76–87.
Winokur, A, Maislin, G, Phillips, JL and Amsterdam, JD (1988) Insulin resistance after oral glucose tolerance testing in patients with major depression. American Journal of Psychiatry 145(3), 325–330.
Wright, JH, Jacisin, JJ, Radin, NS and Bell, RA (1978) Glucose-metabolism in unipolar depression. British Journal of Psychiatry 132, 386–393.
Yu, JT, Tan, L, Song, JH, Sun, YP, Chen, W, Miao, D and Tian, Y (2009) Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer’s disease. Brain Research 1253, 169–175.
Zhao, WQ and Alkon, DL (2001) Role of insulin and insulin receptor in learning and memory. Molecular and Cellular Endocrinology 177(1–2), 125–134.